(Q35199473)

7 August 2017

1 reference

title

Antigen-specific immunotherapy and cancer vaccines (English)

1 reference

7 August 2017

1 reference

3

Alexander Knuth

1 reference

7 August 2017

1

Elke Jäger

1 reference

7 August 2017

Dirk Jäger

2

1 reference

PubMed ID

12918057

7 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

International Journal of Cancer

7 August 2017

1 reference

7 August 2017

106

1 reference

7 August 2017

6

1 reference

7 August 2017

817-820

1 reference

Progress in human tumour immunology and immunotherapy

7 August 2017

1 reference

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

Clinical cancer vaccine trials

21 January 2018

1 reference

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

21 January 2018

1 reference

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

21 January 2018

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

21 January 2018

1 reference

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

21 January 2018

1 reference

Oncogenic proteins as tumor antigens

21 January 2018

1 reference

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

21 January 2018

1 reference

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

21 January 2018

1 reference

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma

21 January 2018

1 reference

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

21 January 2018

1 reference

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

21 January 2018

1 reference

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

21 January 2018

1 reference

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

21 January 2018

1 reference

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

Natural killer cells and dendritic cells: rendezvous in abused tissues

21 January 2018

1 reference

Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.

21 January 2018

1 reference

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life

21 January 2018

1 reference

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.11292

1 reference

7 August 2017

1 reference

PubMed ID

12918057